Dose–Risk and Duration–Risk Relationships between Aspirin and Colorectal Cancer: A Meta-Analysis of Published Cohort Studies
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Dose–Risk and Duration–Risk Relationships between Aspirin and Colorectal Cancer: A Meta-Analysis of Published Cohort Studies
Authors
Keywords
Colorectal cancer, Meta-analysis, Publication ethics, Cohort studies, Colon, Observational studies, Cancer epidemiology, Research reporting guidelines
Journal
PLoS One
Volume 8, Issue 2, Pages e57578
Publisher
Public Library of Science (PLoS)
Online
2013-02-26
DOI
10.1371/journal.pone.0057578
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Aspirin and cancer risk: a quantitative review to 2011
- (2012) C. Bosetti et al. ANNALS OF ONCOLOGY
- Non-steroidal anti-inflammatory drugs and cancer incidence by sex in the VITamins And Lifestyle (VITAL) cohort
- (2012) Theodore M. Brasky et al. CANCER CAUSES & CONTROL
- Effects of regular aspirin on long-term cancer incidence and metastasis: a systematic comparison of evidence from observational studies versus randomised trials
- (2012) Annemijn M Algra et al. LANCET ONCOLOGY
- Non-Steroidal Anti-Inflammatory Drugs and Colorectal Cancer Risk in a Large, Prospective Cohort
- (2011) Elizabeth H Ruder et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Aspirin and cancer: has aspirin been overlooked as an adjuvant therapy?
- (2011) R E Langley et al. BRITISH JOURNAL OF CANCER
- Prevention by daily soluble aspirin of colorectal adenoma recurrence: 4-year results of the APACC randomised trial
- (2011) Robert Benamouzig et al. GUT
- Long-term effect of aspirin on cancer risk in carriers of hereditary colorectal cancer: an analysis from the CAPP2 randomised controlled trial
- (2011) John Burn et al. LANCET
- Effect of aspirin and NSAIDs on risk and survival from colorectal cancer
- (2010) Farhat V N Din et al. GUT
- Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008
- (2010) Jacques Ferlay et al. INTERNATIONAL JOURNAL OF CANCER
- Long-term effect of aspirin on colorectal cancer incidence and mortality: 20-year follow-up of five randomised trials
- (2010) Peter M Rothwell et al. LANCET
- Effect of daily aspirin on long-term risk of death due to cancer: analysis of individual patient data from randomised trials
- (2010) Peter M Rothwell et al. LANCET
- Aspirin and other non-steroidal anti-inflammatory drugs and risk of colorectal cancer: A Danish cohort study
- (2009) Søren Friis et al. CANCER CAUSES & CONTROL
- Aspirin for the Chemoprevention of Colorectal Adenomas: Meta-analysis of the Randomized Trials
- (2009) Bernard F. Cole et al. JNCI-Journal of the National Cancer Institute
- Aspirin, salicylates, and cancer
- (2009) Peter C Elwood et al. LANCET
- Two Subtypes of Mucinous Adenocarcinoma of The Colorectum: Clinicopathological and Genetic Features
- (2008) Sarli Leopoldo et al. ANNALS OF SURGICAL ONCOLOGY
- Similar reductions in the risk of human colon cancer by selective and nonselective cyclooxygenase-2 (COX-2) inhibitors
- (2008) Randall E Harris et al. BMC CANCER
- NSAIDs and apoptosis
- (2008) N. R. Jana CELLULAR AND MOLECULAR LIFE SCIENCES
- Aspirin and Folic Acid for the Prevention of Recurrent Colorectal Adenomas
- (2007) Richard F.A. Logan et al. GASTROENTEROLOGY
- Aspirin Dose and Duration of Use and Risk of Colorectal Cancer in Men
- (2007) Andrew T. Chan et al. GASTROENTEROLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now